Skip to main content

Immunization

Exhibiting 103 entries found in the GMN corpus.

YearTitle & TagsAuthor(s)
1953 CE‘Actively acquired tolerance’ of foreign cells.
1965 CEA “new” antigen in leukemia sera.
1934 CEA new antigen of B. typhosus. Its relation to virulence and to active and passive immunisation.
1800 CE​–1802 CEA prospect of exterminating the small-pox, being the history of the variolae vaccinae, or kine-pox, commonly called the cow-pox; as it has appeared in England: With an account of a series of inoculations performed for the kine-pox in Massachusetts. [Part II:] A prospect of exterminating the small pox part II, being a continuation of a narrative of facts concerning the progress of the new inoculation in America; together with practical observations on the local appearance, symptoms, and mode of treating the variola vaccina, or kine pock; including some letters to the author, from distinguished characters, on the subject of this benign remedy, now passing with a rapid step through all ranks of society in Europe and America.
1935 CEA protective action of neurotropic against viscerotropic yellow fever virus in Macacus rhesus.
1924 CEA scarlet fever antitoxin.
1939 CEA study in active immunization against pertussis.
1928 CEA yellow fever vaccine.
1914 CEActive immunization in diphtheria and treatment by toxin-antitoxin.
1939 CEAn electrophoretic study of immune sera and purified antibody preparations.
1798 CEAn inquiry into the causes and effects of the variolae vaccinae.
1915 CEAn investigation on the nature of ultra-microscopic viruses.
1966 CEAttenuated rubella virus. II. Production of an experimental live-virus vaccine and clinical trial.
1909 CEBeiträge zur experimentellen Pathologie und Chemotherapie.
1944 CEChemical, clinical, and immunological studies on the products of human plasma fractionation. XII. The use of concentrated normal human serum gamma globulin (human immune serum globulin) in the prevention and attenuation of measles.
1956 CE​–1960 CECollected papers of Paul Ehrlich. Compiled and edited by F. Himmelweit. 3 vols.
1895 CEContribution à l’ étude du sérum chez les animaux vaccinés.
1894 CEContribution à l’étude de la diphtérie (sérum thérapie).
1888 CE​–1889 CEContribution a l’étude de la diphtérie.
2020 CECOVID-19 vaccine development and a potential nanomaterial path forward.
1949 CECultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues.
1888 CEDe l’immunité contre le virus de la fièvre typhoöde conférée par des substances solubles.
1893 CEDie Behandlung der Diphtherie mit Diphtherieheilserum.
1913 CEDie Diphtherietoxin – Hautreaktion des Menschen als Vorprobe der prophylaktischen Diphtherieheilseruminjektion.
1897 CEDie Wertbestimmung des Diphtherieheilserums.
2021 CEEfficacy and safety of the mRNA-1273 SARSCov-2 vaccine.
1924 CEEssai d’immunisation contre l’infection tuberculeuse.
1926 CEEssai de prophylaxie des trypanosomiases par des dérivés phénylarsiniques administré
1956 CEFreeze-dried B.C.G. vaccination of newborn infants with a British vaccine.
1893 CE​–1915 CEGesammelte Abhandlungen zur ätiologischen Therapie von ansteckenden Krankheiten. 2 vols.
1902 CEHämolysine, Cytotoxine and Präcipitine.
1910 CEHandbuch der experimentellen Serumtherapie.
1972 CEHistocompatibility-linked immune response genes.
1973 CEHuman cell culture rabies vaccine. Antibody response in man.
1887 CEHydrophobia: An account of M. Pasteur's system containing a translation of all his communications on the subject, the technique of his method, and the latest statistical results
1952 CEImmune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus.
1925 CEImmunisation locale; pansements spécifiques.
1890 CEImmunisirungsversuche bei Diphtherie.
1946 CEImmunity in mumps. VI. Experiments on the vaccination of human beings with formolized mumps virus.
1955 CEImmunization of chimpanzees and human beings with avirulent strains of poliomyelitis virus.
1960 CEImmunosassay of endogenous plasma insulin in man.
1906 CEInfection, immunity and serum therapy.
1930 CEInsoluble precipitates in diphtheria and tetanus immunization.
1958 CEIso-leuco-anticorps.
1928 CEL’anatoxine diphtérique. Ses propriétés–ses applications.
1895 CELa peste bubonique. By Alexandre Yersin with L.C.A. Calmette and A. Borrel.
1927 CELa vaccination préventive contre la tuberculose par le "BGG". Par Albert Calmette avec la collaboration de C. Guérin, A. Boquet et L. Nègre.
1892 CELe choléra asiatique chez le cobaye.
1881 CELes injections de virus rabique dans le torrent circulatoire ne provoquent pas l’éclosion de la rage et semblant conférer l’immunité. La rage peut être transmise par l’ingestion de la matiére rabique.
1906 CELes inoculations antipesteuses.